skip to main content

COPD exacerbation prevention — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardRespiratory TherapeuticsCOPD exacerbation preventionGPhC CRA

A 69-year-old ex-smoker with COPD collects salbutamol inhalers monthly. He reports two exacerbations requiring prednisolone in six months and mMRC breathlessness grade 3. His eosinophil count is 0.4 x 10^9/L. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CRefer for COPD review because frequent exacerbations suggest escalation beyond SABA therapy

Frequent COPD exacerbations and persistent breathlessness require review of diagnosis, inhaler technique, adherence and maintenance therapy. SABA alone is insufficient for ongoing COPD symptoms with repeated exacerbations. Escalation decisions depend on symptoms, exacerbation history, eosinophils and risk of adverse effects. Pharmacy action should prompt structured clinical review rather than unsupervised changes.

Reference: NICE CKS; BNF